Blog
Business Development Manager
By Helen Johnstone•June 10, 2026
We’re looking for a proactive and commercially minded Business Development Manager to join our growing team.
The Digital Lab of the Future: From Connected Data to Intelligent Orchestration
By Nicola Dennis•February 20, 2026
One thing is becoming increasingly clear. The Lab of the Future isn’t defined by any single technology. It’s defined by how everything works together.
2025 End of Year Message from Elixir Software CEO Dr. Paul Faulder
By Nicola Dennis•December 15, 2025
"2025 underscored the people, expertise and purpose that sit at the centre of Elixir's success. We move into 2026 with confidence and momentum."
Elixir Software CEO Dr. Paul Faulder on Pharma Now Podcast: Can iTraX save R&D?
By Nicola Dennis•October 31, 2025
Elixir Software CEO Dr. Paul Faulder features on Pharma Now podcast, showcasing how iTraX is transforming pharma R&D.
03: Meeting growth challenges; evolving scientific software deployment
By Ray Tran•October 22, 2025
No. 03 | The science of software infrastructure | The third post in our thought leadership series.
Case Studies
Visualized workflows in Pharma and Biotech R&D.
iTraX case study - Transforming Study Management
By Nicola Dennis•February 3, 2025
How iTraX significantly improved efficiency for toxicology and bioanalytical study management in a mid-sized biotech company.
iTraX Study Management case study - US global biotech client
By Nicola Dennis•December 16, 2020
A US-based global biotechnology company had a commonly seen challenge in Laboratory Animal Science (LAS). Biopharmaceutical LAS teams receive multiple project requests for studies and need to schedule the delivery of tasks by relevant skilled technicians, with the available and designated time slots. In conversation with their clients, Elixir learned that many of the currently available tools used for LAS are disconnected and inefficient for effective study planning, tracking and delivery. The use of multiple emails, calendars and isolated files e.g., spreadsheets has resulted in a complex process, that is typically maintained through time-consuming daily meetings.
iTraX Chemistry case study - Boston biotech client
By Nicola Dennis•October 29, 2020
This clinical-stage biopharmaceutical company’s chemistry engine combined in-house medicinal chemistry design with external synthesis capabilities. It was critical for them to have a robust process for tracking the design cycle (Design-Make-Test-Analyze) to assure expedient execution and quality decision making. A specific technical challenge, common to many institutions, is unambiguous tracking of synthetic targets across multiple projects and partners. Issues may and do arise from keeping track of the target status, changes in the target priority, and other synthetic queue modifications. In common with many growing biotech companies, a Boston-based biotech augments its in-house chemistry team with tens of synthetic chemists from multiple CRO partners. While this enables the company to significantly increase its capacity, it also brings the challenge of coordinating work between multiple organizations around the globe.
iTraX Chemistry case study - Clinical-stage biopharma client
By Nicola Dennis•September 28, 2020
Elixir Software was founded in 2012 by Dr Paul Faulder and Dr Martin Harrison, with the purpose of creating software to improve the efficiency of teamwork in the scientific R&D community. Its innovative workflow management tool iTraX was created to set a new industry standard for project delivery through collaboration.
The flagship platform, iTraX Chemistry unifies design, synthesis and registration in a single, chemistry-aware workspace. It allows users to track and manage projects in-house, and with CROs and external partners via an intuitive Kanban board.
Today, iTraX is used by 50+ enterprise clients across four continents, helping to drive projects forward and discover the next breakthrough medicines faster.
iTraX™| A software solution from Elixir Software Ltd.